Found: 24
Select item for more details and to access through your institution.
Alternative Approach to BIPSS in the Differential Diagnosis of ACTH-Dependent Cushing Syndrome.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 6, p. e1460, doi. 10.1210/clinem/dgad676
- By:
- Publication type:
- Article
Skeletal Muscle Evaluation in Patients With Acromegaly.
- Published in:
- Journal of the Endocrine Society, 2024, v. 8, n. 4, p. 1, doi. 10.1210/jendso/bvae032
- By:
- Publication type:
- Article
Evaluation of bone mineral density, microarchitecture, and detection of fractures on young patients living with human immunodeficiency virus: when and how to screen?
- Published in:
- Endocrine (1355008X), 2024, v. 83, n. 1, p. 214, doi. 10.1007/s12020-023-03501-9
- By:
- Publication type:
- Article
Long-term Efficacy and Safety of Pasireotide in Patients With Acromegaly: 14 Years of Single-Center Real-World Experience.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 12, p. e1571, doi. 10.1210/clinem/dgad378
- By:
- Publication type:
- Article
miR-383-5p, miR-181a-5p, and miR-181b-5p as Predictors of Response to First-Generation Somatostatin Receptor Ligands in Acromegaly.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2875, doi. 10.3390/ijms24032875
- By:
- Publication type:
- Article
Routine Evaluation of Somatostatin Receptor Type 2 in Patients With Acromegaly: Do We Still Need More Evidence?
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 12, p. e4382, doi. 10.1210/clinem/dgac584
- By:
- Publication type:
- Article
Pituitary acting drugs: cabergoline and pasireotide.
- Published in:
- Pituitary, 2022, v. 25, n. 5, p. 722, doi. 10.1007/s11102-022-01238-8
- By:
- Publication type:
- Article
Telomere length and Wnt/β-catenin pathway in adamantinomatous craniopharyngiomas.
- Published in:
- European Journal of Endocrinology, 2022, v. 187, n. 2, p. 219, doi. 10.1530/EJE-21-1269
- By:
- Publication type:
- Article
Approach to the Patient: Differential Diagnosis of Cystic Sellar Lesions.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 6, p. 1751, doi. 10.1210/clinem/dgac033
- By:
- Publication type:
- Article
Pituitary MRI Standard and Advanced Sequences: Role in the Diagnosis and Characterization of Pituitary Adenomas.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 5, p. 1431, doi. 10.1210/clinem/dgab901
- By:
- Publication type:
- Article
The Future of Somatostatin Receptor Ligands in Acromegaly.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 2, p. 297, doi. 10.1210/clinem/dgab726
- By:
- Publication type:
- Article
gsp Mutation Is Not a Molecular Biomarker of Long-Term Response to First-Generation Somatostatin Receptor Ligands in Acromegaly.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4857, doi. 10.3390/cancers13194857
- By:
- Publication type:
- Article
Machine Learning-based Prediction Model for Treatment of Acromegaly With First-generation Somatostatin Receptor Ligands.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical significance of filamin A in patients with acromegaly and its association with somatostatin and dopamine receptor profiles.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-37692-3
- By:
- Publication type:
- Article
Treatment escape reduces the effectiveness of cabergoline during long‐term treatment of acromegaly in monotherapy or in association with first‐generation somatostatin receptor ligands.
- Published in:
- Clinical Endocrinology, 2018, v. 88, n. 6, p. 889, doi. 10.1111/cen.13595
- By:
- Publication type:
- Article
Predictors of surgical outcome and early criteria of remission in acromegaly.
- Published in:
- Endocrine (1355008X), 2018, v. 60, n. 3, p. 415, doi. 10.1007/s12020-018-1590-8
- By:
- Publication type:
- Article
Molecular evidence and clinical importance of β‐arrestins expression in patients with acromegaly.
- Published in:
- Journal of Cellular & Molecular Medicine, 2018, v. 22, n. 4, p. 2110, doi. 10.1111/jcmm.13427
- By:
- Publication type:
- Article
Apoplexy in nonfunctioning pituitary adenomas.
- Published in:
- Pituitary, 2018, v. 21, n. 2, p. 138, doi. 10.1007/s11102-018-0870-x
- By:
- Publication type:
- Article
Personalized medicine in the treatment of acromegaly.
- Published in:
- European Journal of Endocrinology, 2018, v. 178, n. 3, p. R89, doi. 10.1530/EJE-17-1006
- By:
- Publication type:
- Article
Dopamine receptor subtype 2 expression profile in nonfunctioning pituitary adenomas and in vivo response to cabergoline therapy.
- Published in:
- Clinical Endocrinology, 2015, v. 82, n. 5, p. 739, doi. 10.1111/cen.12684
- By:
- Publication type:
- Article
Rotation thromboelastometry and the hypercoagulable state in Cushing's syndrome.
- Published in:
- Clinical Endocrinology, 2014, v. 81, n. 5, p. 657, doi. 10.1111/cen.12491
- By:
- Publication type:
- Article
<i>ZAC1</i> and <i>SSTR2</i> Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0077406
- By:
- Publication type:
- Article
Ki-67 is a predictor of acromegaly control with octreotide LAR independent of SSTR2 status and relates to cytokeratin pattern.
- Published in:
- European Journal of Endocrinology, 2013, v. 169, n. 2, p. 217, doi. 10.1530/EJE-13-0349
- By:
- Publication type:
- Article
Low Aryl Hydrocarbon Receptor-Interacting Protein Expression Is a Better Marker of Invasiveness in Somatotropinomas than Ki-67 and p53.
- Published in:
- Neuroendocrinology, 2011, v. 94, n. 1, p. 39, doi. 10.1159/000322787
- By:
- Publication type:
- Article